Author

Kunal Biswas

Mazumdar Shaw Medical Foundation

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Chakenahalli N. Naveenkumar· 1 shared Gudepalya Renukaiah RudramurthyiD· 1 shared K. Bharathkumar· 1 shared Manjula DasiD· 1 shared Naga Puspha Battula· 1 shared Pushkarni Suresh· 1 shared R.K. Shandil· 1 shared Sakshi Sinha· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Chakenahalli N. Naveenkumar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Recombinant Human ACE2-Fc : A promising therapy for SARS-CoV2 infection

Smitha P.K., R.K. Shandil, Pushkarni Suresh, Kunal Biswas, Gudepalya Renukaiah Rudramurthy, Chakenahalli N. Naveenkumar, K. Bharathkumar, Naga Puspha Battula, Suprabuddha Datta Chowdhury, Sakshi Sinha, Sarmistha Dutta, Sujan Kumar Dhar, Shridhar Narayanan, Manjula Das

This paper describes a recombinant ACE2-Fc protein that neutralizes SARS-CoV2 in vitro and in vivo, with pharmacokinetic properties and a novel in vitro model for SARS-CoV2 infection.

bioRxiv · Jul 30, 2022 · PreprintMolecular Biology